פעילות רפואית
Trabectedin Teva is indicated for the treatment of patients with advanced soft tissue sarcoma,
after failure of anthracyclines and ifosfamide, or who are unsuited to receive these agents.
Efficacy data are based mainly on liposarcoma and leiomyosarcoma patients.